No Detail Found!

RESPONSE RATE OF SOFOSBUVIR BASED ANTIVIRAL THERAPY AMONG PATIENTS INFECTED WITH HEPATITIS C VIRUS GENOTYPE 3A

Author(s)
Ijaz Ali Department of Biosciences, COMSATs University Islamabad, Pakistan
Amina Gul Department of Pathology, Khyber Medical College Peshawar, Pakistan
Atika Noorul Sahar Department of Biosciences, COMSATs University Islamabad, Pakistan
Shahid Niaz Khan Department of Zoology, Kohat University of Science and Technology Kohat, Pakistan
Sadeequr Rahman College of Veterinary Sciences and AH, Abdul Wali Khan University Mardan, Pakistan
Imtiaz Ali Khan Department of Microbiology, The University of Swabi, Pakistan.
Johar Jamil Department of Microbiology, The University of Swabi, Pakistan.
Abstract
Objective: To evaluate the efficacy of dual therapy of Sofosbuvir and Ribavirin among treatment-naive and non-re­sponders of Interferon based antiviral regimens against HCV genotype 3a infected patients. Material & Methods: A longitudinal study was conducted on 100 HCV genotype 3a infected patients from December 2016 to September 2017. Patients were initially divided into two groups including Group-A (n=50/100) as treatment naive, and Group-B (n=50/100) including non-responders. All patients received Sofosbuvir and RBV for 24weeks. HCV genotype was determined using Type-specific nested PCR based genotyping assay. Viral RNA was detected using qualitative or real-time PCR. Results: After 4 weeks of treatment, HCV RNA was undetectable in 100 of Group A patients, while Group B patients achieved 92% RVR. SVR12 was 96% in treatment naïve Group A patients, while Group B patients achieved an SVR12 of 90%. There were no significant differences in the SVR12 rates between the two treatment groups (Pearson Chi-Square test, p-value >0.05). The association of RVR and SVR12 was found statistically significant (Pearson Chi-Square test, p- value<0.05). Conclusion: Sofosbuvir and RBV is highly effective among the treatment-naive and previously treated chronic HCV genotype 3a infected patients.
Publication Details
Page(s) 295-301
DOI DOI not available
Published Journal: Journal of Medical Science, Volume: 27, Issue: 4, Year: 2019

Request the full text from PASTIC

Keywords
Sofosbuvir, HCV genotype 3a, SVR12
0

Citations

0

Downloads

46

Views